v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (28,779) $ (26,313)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 1,408 1,800
Impairment of property and equipment 13
Unrealized gain on derivative liability (842)
Unrealized gain on warrant liability (1,761)
Loss on debt extinguishment 4,654
Inventory write-downs 9
Non-cash interest expense 7,325
Amortization of debt discount and issuance costs on notes payable 5,559
Share-based compensation expense 1,921 3,743
Net accretion of premium on short-term investments (118) (288)
Change in:    
Accounts receivable 674 (172)
Inventory (228) 102
Other current and non-current assets (2,713) 992
Accounts payable 95 (527)
Accrued liabilities (348) 1,331
Contract liabilities and other current liabilities (342) (480)
Operating lease liabilities (556) (639)
Other long-term liabilities (47) (330)
Net cash used in operating activities (14,098) (20,759)
Cash flows from investing activities    
Sales of investment securities 13,522 7,900
Purchases of investment securities (10,333) (7,805)
Purchases of property and equipment (99) (114)
Cash paid for Ibeo business combination (3,263)
Net cash provided by (used in) investing activities 3,090 (3,282)
Cash flows from financing activities    
Principal payments under finance leases (2)
Proceeds from stock option exercises 62
Net proceeds from issuance of common stock and warrants 8,207 20,956
Net cash provided by financing activities 8,205 21,018
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 81 (31)
Change in cash, cash equivalents, and restricted cash (2,722) (3,054)
Cash, cash equivalents, and restricted cash at beginning of period 56,247 49,391
Cash, cash equivalents, and restricted cash at end of period 53,525 46,337
Supplemental schedule of non-cash investing and financing activities    
Common stock issued in conversions of notes payable 21,980
Issuance of warrants 6,297
Acquisition of right-of-use asset (107)
Non-cash additions to property and equipment 21
Accrued liability for Ibeo business combination 2,969
Accrued financing fees 41 396
Foreign currency translation adjustment 138 (19)
Unrealized gain (loss) in investment securities, available-for-sale $ (19) $ (34)

Source

HTML PDF
ZIP